Attached files
| file | filename |
|---|---|
| EX-99.1 - Lineage Cell Therapeutics, Inc. | ex99-1.htm |
| EX-32 - Lineage Cell Therapeutics, Inc. | ex32.htm |
| EX-31 - Lineage Cell Therapeutics, Inc. | ex31.htm |
| EX-23.2 - Lineage Cell Therapeutics, Inc. | ex23-2.htm |
| EX-23.1 - Lineage Cell Therapeutics, Inc. | ex23-1.htm |
| EX-10.38 - Lineage Cell Therapeutics, Inc. | ex10-38.htm |
| 10-K - Lineage Cell Therapeutics, Inc. | form10-k.htm |
Exhibit 21.1
List of Subsidiaries
| Subsidiary | BioTime Ownership | Country | ||||
| AgeX Therapeutics, Inc. | 85.4 | % | USA | |||
| Cell Cure Neurosciences Ltd. | 98.8 | %(1) | Israel | |||
| ES Cell International Pte. Ltd. | 100 | % | Singapore | |||
| LifeMap Sciences, Inc. | 81.7 | %(2) | USA | |||
| LifeMap Sciences, Ltd. | (3) | Israel | ||||
| OrthoCyte Corporation | 99.8 | % | USA | |||
| ReCyte Therapeutics, Inc. | 94.8 | %(2) | USA | |||
| (1) | Includes shares owned by BioTime and ES Cell International Pte Ltd. | |
| (2) | Represents shares owned by AgeX Therapeutics, Inc. | |
| (3) | LifeMap Sciences, Ltd. is a wholly-owned subsidiary of LifeMap Sciences, Inc. |